Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Methotrexate and Area Under the Curve Exposure in Patients Receiving MT-R for Primary CNS Lymphoma: A Single Institution Retrospective Study

Alex G Sieg, MD MS, Christopher Strouse, MD, Sarah L Mott, Joshua Reeder, Sergei Syrbu, MD PhD, Guohua An, MD PhD, Grerk Sutamtewagul, MD, Brian K. Link, MD, Umar Farooq, MD

Blood (2019) 134 (Supplement_1): 1626.

https://doi.org/10.1182/blood-2019-127349

Published: 2019

Journal Articles

Diagnostic Potential of Five Different Biomechanical Parameters to Detect Sclerotic Cutaneous Graft-Versus-Host Disease

Fuyao Chen, BS, Laura Wang, BS, Yvette Ssempijja, BS, Arved Vain, PhD, Madan Jagasia, MBBS, MS, MMHC, Eric R. Tkaczyk, MD PhD

Blood (2019) 134 (Supplement_1): 2002.

https://doi.org/10.1182/blood-2019-129381

Published: 2019

Journal Articles

A Novel Machine Learning Based in silico Pathogenicity Predictor for Missense Variants in a Hematological Setting

Stephan Hutter, PhD, Constance Baer, PhD, Wencke Walter, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 2090.

https://doi.org/10.1182/blood-2019-128488

Published: 2019

Journal Articles

A GUT Microbiota Score Predicting for ACUTE GRAFT-Versus-Host Disease

Lijie Han, PhD, Jie Peng, MD, Ke Zhao, MD, Zhiping Fan, MD, Hua Jin, Haiyan Zhang, MD, Hui Sun, Qifa Liu, MD, Zhongxing Jiang, MD PhD

Blood (2019) 134 (Supplement_1): 1991.

https://doi.org/10.1182/blood-2019-126518

Published: 2019

Journal Articles

Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)

Nathan Radakovich, BA, Mikkael A. Sekeres, MD MS, Cameron Beau Hilton, BA, Sudipto Mukherjee, MD PhD MPH, Jacob Shreve, MD MS, Yazan Rouphail, Rachel Shirley, Vera Adema, PhD, Hassan Awada, MD, Anjali S. Advani, MD, Cassandra M Kerr, MS, Yasunobu Nagata, MD PhD, Yihong Guan, PhD, Teodora Kuzmanovic, BA, Metis Hasipek, PhD, Babal K. Jha, PhD, Jaroslaw P. Maciejewski, MD PhD, Aziz Nazha, MD

Blood (2019) 134 (Supplement_1): 2089.

https://doi.org/10.1182/blood-2019-126275

Published: 2019

Journal Articles

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Kyung Taek Hong, MD, Soyoung Lee, Jaeseong Oh, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Kyung-Sang Yu, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3594.

https://doi.org/10.1182/blood-2019-125266

Published: 2019

Journal Articles

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Yang Liang, PhD, Yun Wang, Yan-Yu Cai, Siliang Chen, Run-Cong Nie, Zhe-Yuan Qin, PhD, Fang Hu, Weida Wang, MD, Yu-Jun Dai, PhD

Blood (2019) 134 (Supplement_1): 708.

https://doi.org/10.1182/blood-2019-126733

Published: 2019

Journal Articles

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

Dongwoo Kang, PhD, Julie Passarell, MA, Malaz A Abutarif, PhD, Jeanne Mendell, PhD MPH, Ophelia Yin, PhD

Blood (2019) 134 (Supplement_1): 1263.

https://doi.org/10.1182/blood-2019-122582

Published: 2019

Journal Articles

On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies ("Inhibitors") Directed Against Therapeutic Factor VIII Proteins (tFVIIIs): Evidence from the PATH Study

Vincent P. Diego, PhD, Bernadette W. Luu, B.S., M.T. (CLS), Afshin Ameri, MD, Meera B. Chitlur, MD, Marcio A. Almeida, PhD, Karin Haack, PhD, Satish Kumar, PhD, Long V. Dinh, PhD, Henry Mead, M.B.A., M.P.H., Jerry S. Powell, MD, Miguel A. Escobar, MD, Raja Rajalingam, PhD, Sarah Williams-Blangero, PhD, Carol K. Kasper, MD, Laura Almasy, PhD, Shelley Cole, PhD, John Blangero, PhD, Tom E. Howard, MD, PhD

Blood (2019) 134 (Supplement_1): 2393.

https://doi.org/10.1182/blood-2019-132218

Published: 2019

Journal Articles

Using Machine Learning to Classify the "Goodness" of Hmsc-Derived and AML-Derived EV's

Chibuikem Chukwudalu Nwizu, Lorin Crawford, PhD, Theo Borgovan, MD BS, Sicheng Wen, MD PhD, Mark S Dooner, Pamela C Egan, MD, John L. Reagan, MD, Adam J Olszewski, MD, Laura R Goldberg, MD PhD, Peter J. Quesenberry, MD

Blood (2018) 132 (Supplement 1): 5244.

https://doi.org/10.1182/blood-2018-99-120183

Published: 2018

Journal Articles

Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)

Maro N. Ohanian, DO, Tara L Lin, MD, Ellen K. Ritchie, MD, Michael Craig, MD, Apurv Agrawal, MD, Kathleen G. Halka, MD, Vinit Karur, MD, Naveen Pemmaraju, MD, Gautam Borthakur, MD, Sarah Aminov, Miranda Lim, BSN, Sherry A. Pierce, BSN, BA, Natalie Sacarakis, Stacy Minor, Ana Tari Ashizawa, PhD, William Hahne, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Gail J. Roboz, MD

Blood (2018) 132 (Supplement 1): 1387.

https://doi.org/10.1182/blood-2018-99-113693

Published: 2018

Journal Articles

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

Eric S. Mullins, MD, Davis Stroop, PhD, David Ingala, Cristina Tarango, MD, Lori Luchtman-Jones, MD, Adam Lane, Ralph A. Gruppo, MD

Blood (2017) 130 (Supplement 1): 1048.

https://doi.org/10.1182/blood.V130.Suppl_1.1048.1048

Published: 2017

Journal Articles

Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis

Rocco Piazza, MD PhD, Luca Mologni, PhD, Daniele Ramazzotti, PhD, Roberta Spinelli, MSc, Alessandra Pirola, MSc, Luca De Sano, MSc, Pierangelo Ferrari, Vera Magistroni, PhD, Nitesh Sharma, PhD, Praveen Khandelwal, PhD, Carlo Gambacorti-Passerini, MD

Blood (2016) 128 (22): 3075.

https://doi.org/10.1182/blood.V128.22.3075.3075

Published: 2016

Journal Articles

Routine Blood Investigations Have Limited Utility in Routine Surveillance of High-Grade Lymphomas (HGL) in Remission after First-Line Therapy

Zoe Loh, Leigh Beveridge, MBBS, Andrew P Grigg, MBBS MD, Ortis Estacio, Geoff Chong, MD, Francis Ha, Michael Gilbertson, Eliza A Hawkes

Blood (2016) 128 (22): 3040.

https://doi.org/10.1182/blood.V128.22.3040.3040

Published: 2016

Journal Articles

A Novel BRD4 Inhibitor CA2 Suppresses MM Cell Proliferation in an Orthotopic Myeloma Mouse Model

Natsuki Imayoshi, Makoto Yoshioka, PhD, Susumu Nakata, MD PhD, Jay Chauhan, PhD, Yoko Kado, BS, Yuki Toda, PhD, Steven Fletcher, PhD, Jeffrey Strovel, PhD, Kazuyuki Takata, PhD, Eishi Ashihara, MD PhD

Blood (2016) 128 (22): 4722.

https://doi.org/10.1182/blood.V128.22.4722.4722

Published: 2016

Journal Articles

Comparison of Two Rapid Predictive Methods for Therapeutic Targeting in Acute Myeloid Leukaemia Cells

Martin Grundy, PhD, Jones Thomas, BSc, Liban Elmi, B MDSci, Michael Hall, B MDSci, Nigel H Russell, MD, Monica Pallis, PhD

Blood (2016) 128 (22): 1704.

https://doi.org/10.1182/blood.V128.22.1704.1704

Published: 2016

Journal Articles

Canine Neutrophil Extracellular Traps Have Pro-Coagulant and Anti-Fibrinolytic Effects

Unity Jeffery, VetMB PhD DACVP (clinical pathology), Dana N. LeVine, DVM, PhD DACVIM

Blood (2016) 128 (22): 3813.

https://doi.org/10.1182/blood.V128.22.3813.3813

Published: 2016

Journal Articles

Therapeutic Cyclosporine Exposure Measured As Area Under the Curve (AUC) Significantly Influences the Outcome after Allogeneic Hematopoetic Stem Cell Transplant (alloHSCT)

Samar Kulkarni, MD MRCP, FRCPath, John Murray, BSc (hons), MSc, Michael Dennis, FRCPath, Jim Cavet, FRCPath, Anna Z Castleton, FRCPath, Tim Somervaille, MDPhD, Daniel Wiseman, FRCPath, Joanna Tomlins, MSc, Adrian Bloor

Blood (2016) 128 (22): 2237.

https://doi.org/10.1182/blood.V128.22.2237.2237

Published: 2016

Journal Articles

Using Machine Intelligence Algorithms to Develop a Geno-Clinical Model to Predict Responses to Hypomethylating Agents in Myelodysplastic Syndromes

Aziz Nazha, MD, Mikkael A. Sekeres, MD MS, Rafael Bejar, MD PhD, John Barnard, PhD, Karam Al-Issa, MD, Bartlomiej P Przychodzen, MSc, Matt Kalaycio, MD, Michael J. Clemente, M.S., Cassandra M. Hirsch, BSc, Benjamin L Ebert, MD PhD, Jaroslaw P. Maciejewski

Blood (2016) 128 (22): 3193.

https://doi.org/10.1182/blood.V128.22.3193.3193

Published: 2016

Journal Articles

Pharmacokinetics of Red Cell-Derived Microparticles (RMP) in Rabbits and Rats: Effects of Administration Regimen and Labels for Assay

Wenche Jy, PhD, Carlos Bidot, Jr., BS, Lawrence L Horstman, BS, Rifat Pamukcu, MD, Yeon-Soong Ahn, MD

Blood (2015) 126 (23): 1146.

https://doi.org/10.1182/blood.V126.23.1146.1146

Published: 2015

NARROW

Methotrexate and Area Under the Curve Exposure in Patients Receiving MT-R for Primary CNS Lymphoma: A Single Institution Retrospective Study

Diagnostic Potential of Five Different Biomechanical Parameters to Detect Sclerotic Cutaneous Graft-Versus-Host Disease

A Novel Machine Learning Based in silico Pathogenicity Predictor for Missense Variants in a Hematological Setting

A GUT Microbiota Score Predicting for ACUTE GRAFT-Versus-Host Disease

Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies ("Inhibitors") Directed Against Therapeutic Factor VIII Proteins (tFVIIIs): Evidence from the PATH Study

Using Machine Learning to Classify the "Goodness" of Hmsc-Derived and AML-Derived EV's

Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)

Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects

Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis

Routine Blood Investigations Have Limited Utility in Routine Surveillance of High-Grade Lymphomas (HGL) in Remission after First-Line Therapy

A Novel BRD4 Inhibitor CA2 Suppresses MM Cell Proliferation in an Orthotopic Myeloma Mouse Model

Comparison of Two Rapid Predictive Methods for Therapeutic Targeting in Acute Myeloid Leukaemia Cells

Canine Neutrophil Extracellular Traps Have Pro-Coagulant and Anti-Fibrinolytic Effects

Therapeutic Cyclosporine Exposure Measured As Area Under the Curve (AUC) Significantly Influences the Outcome after Allogeneic Hematopoetic Stem Cell Transplant (alloHSCT)

Using Machine Intelligence Algorithms to Develop a Geno-Clinical Model to Predict Responses to Hypomethylating Agents in Myelodysplastic Syndromes

Pharmacokinetics of Red Cell-Derived Microparticles (RMP) in Rabbits and Rats: Effects of Administration Regimen and Labels for Assay

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only